Aclaris Therapeutics Inc
SWB:8AT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aclaris Therapeutics Inc
SWB:8AT
|
US |
|
J
|
Jack in the Box Inc
SWB:JBX
|
US |
|
O
|
Oil and Gas Development Co Ltd
KAR:OGDC
|
PK |
|
L
|
Leifheit AG
F:LEI
|
DE |
|
F
|
Fresh Vine Wine Inc
AMEX:VINE
|
US |
|
S
|
Stratasys Ltd
SWB:SCY
|
US |
|
I
|
Invesco Mortgage Capital Inc
F:7M2
|
US |
|
E
|
Engie SA
XHAN:GZF
|
FR |
Wall St Price Targets
8AT Price Targets Summary
Aclaris Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 8AT is 7.398 EUR with a low forecast of 3.202 EUR and a high forecast of 10.82 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8AT's stock price target?
Price Target
7.398
EUR
According to Wall Street analysts, the average 1-year price target for 8AT is 7.398 EUR with a low forecast of 3.202 EUR and a high forecast of 10.82 EUR.
What is the Revenue forecast for Aclaris Therapeutics Inc?
Projected CAGR
67%
The compound annual growth rate for Revenue over the next 8 years is 67%.
What is the Gross Profit forecast for Aclaris Therapeutics Inc?
Projected CAGR
174%
The compound annual growth rate for Gross Profit over the next 5 years is 174%.
